These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 31233177)

  • 1. Dupilumab in Treatment of Chronic Prurigo: A Case Series and Literature Review.
    Almustafa ZZ; Weller K; Autenrieth J; Maurer M; Metz M
    Acta Derm Venereol; 2019 Sep; 99(10):905-906. PubMed ID: 31233177
    [No Abstract]   [Full Text] [Related]  

  • 2. Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo.
    Chiricozzi A; Maurelli M; Gori N; Argenziano G; De Simone C; Calabrese G; Girolomoni G; Peris K
    J Am Acad Dermatol; 2020 Jul; 83(1):39-45. PubMed ID: 32229281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index.
    Ariëns LFM; Gadkari A; van Os-Medendorp H; Ayyagari R; Terasawa E; Kuznik A; Chen Z; Bégo-Le Bagousse G; Lu Y; Rizova E; Graham NMH; Pirozzi G; De Bruin-Weller M; Eckert L
    Acta Derm Venereol; 2019 Sep; 99(10):851-857. PubMed ID: 31099402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response.
    Husein-ElAhmed H; Steinhoff M
    J Dermatolog Treat; 2022 May; 33(3):1547-1553. PubMed ID: 33200955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dupilumab Treatment for Prurigo Nodularis and Pruritis.
    Tanis R; Ferenczi K; Payette M
    J Drugs Dermatol; 2019 Sep; 18(9):940-942. PubMed ID: 31524352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of dupilumab in patients who are HIV-positive: report of four cases.
    Mollanazar NK; Qiu CC; Aldrich JL; Tedaldi E; Valdes-Rodriguez R; Savage KT; Hsu S
    Br J Dermatol; 2019 Dec; 181(6):1311-1312. PubMed ID: 31206599
    [No Abstract]   [Full Text] [Related]  

  • 7. Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series.
    Mareschal A; Puzenat E; Aubin F
    Acta Derm Venereol; 2020 Jan; 100(1):adv00014. PubMed ID: 31709451
    [No Abstract]   [Full Text] [Related]  

  • 8. A critical review of dupilumab for adult patients with prurigo nodularis.
    Biazus Soares G; Yosipovitch G
    Expert Rev Clin Immunol; 2024 Mar; 20(3):249-254. PubMed ID: 37811660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ustekinumab in severe complicated erythrodermic psoriasis: rapid clearing, safety, and sustained remission.
    Koutsoukou XA; Papadavid E; Theodoropoulos K; Rigopoulos D
    Dermatol Ther; 2014; 27(5):257-9. PubMed ID: 24813816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Effectiveness of Dupilumab in Prurigo Nodularis.
    Romano C
    J Investig Allergol Clin Immunol; 2021 Apr; 31(2):162-163. PubMed ID: 32573461
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of dupilumab in patients with prurigo nodularis.
    Li X; Li J; Li D; Guo J; Yang X; Fan C; Cai H; An C; Li Y; Zhang J
    Arch Dermatol Res; 2024 Oct; 316(10):676. PubMed ID: 39400706
    [No Abstract]   [Full Text] [Related]  

  • 12. Effective control of recalcitrant pruritus by bevacizumab: a possible role for vascular endothelial growth factor in chronic itch?
    Krause K; Krull C; Kessler B; Lange-Asschenfeldt B; Maurer M; Metz M
    Acta Derm Venereol; 2013 Mar; 93(2):175-9. PubMed ID: 22930318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remittive effect of Dupilumab in atopic dermatitis.
    Treister AD; Lio PA
    Dermatol Ther; 2018 Nov; 31(6):e12711. PubMed ID: 30253014
    [No Abstract]   [Full Text] [Related]  

  • 14. Dupilumab in Inflammatory Skin Diseases: A Systematic Review.
    Olbrich H; Sadik CD; Ludwig RJ; Thaçi D; Boch K
    Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dupilumab for prurigo nodularis: Case series and review of the literature.
    Holm JG; Agner T; Sand C; Thomsen SF
    Dermatol Ther; 2020 Mar; 33(2):e13222. PubMed ID: 31917498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Itch Associated With Dupilumab Treatment In 4 Patients With Prurigo Nodularis.
    Mollanazar NK; Elgash M; Weaver L; Valdes-Rodriguez R; Hsu S
    JAMA Dermatol; 2019 Jan; 155(1):121-122. PubMed ID: 30427989
    [No Abstract]   [Full Text] [Related]  

  • 17. [Successful treatment of chronic prurigo with dupilumab].
    Winkler JK; Haenssle HA; Enk A; Toberer F; Hartmann M
    Hautarzt; 2021 Jun; 72(6):528-532. PubMed ID: 33180178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of dupilumab in prurigo nodularis in elderly patient.
    Giura MT; Viola R; Fierro MT; Ribero S; Ortoncelli M
    Dermatol Ther; 2020 Jan; 33(1):e13201. PubMed ID: 31856368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dupilumab shows slow, steady effectiveness for intractable prurigo in patients with atopic dermatitis.
    Takeuchi S; Inoue K; Kuretake K; Kiyomatsu-Oda M; Furue M
    J Dermatol; 2021 May; 48(5):638-644. PubMed ID: 33742710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Dupilumab in Pediatric Patient With Prurigo Nodularis-Like Atopic Dermatitis.
    Yiling Y; Ali K; Jiayang D; Qiu Y; Kai G; JinPeng S; Tianci X; Min C; Menghua L; Liming W
    Dermatitis; 2023; 34(2):162-163. PubMed ID: 36917530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.